Agreed.

I thought it was a great call - it's what i was expecting for the most part - but learning that we're about to finish our data submission to the FDA for the hold (my read is by YE) was a piece of news that I didn't know before - and it's great news. That makes it a great call to me.

The scientists were all very impressive, and laid out a compelling case for our drug. And Cyrus was very professional and methodical as always.

Sounds like Recknor is gone. On the one hand i'm bummed because he seems like a solid guy - on the other hand, I like that Cyrus is building out his own team, based on his mission for this company. It's like having Phil Jackson or Nick Saban come in - they're not going to keep anyone on staff or on their team that won't lead to a title - and that's the way it should be.

If i had any free cash i'd add some shares just because it's so cheap, and because i think it'll jump once we submit the final 2 pieces, but i'm pretty damn over-allocated as it is